# Mobia Medical to Participate in the Piper Sandler 38th Annual Healthcare Conference

- Published: 2026-11-17
- Author: [Healthcare News](https://healthcarenews.io/author/healthcarenews-io.md)
- Topics: [News](https://healthcarenews.io/news.md)
- Source: https://healthcarenews.io/news/mobia-medical-to-participate-in-the-piper-sandler-38th-annual-healthcare-conference/
- Publication: Healthcare News
- Publisher: Connectively (Terkel, Inc.)
- Editorial policy: https://healthcarenews.io/editorial-policy/

AUSTIN, Texas, Nov. 17, 2026 [(GLOBE NEWSWIRE)](https://www.globenewswire.com) -- Mobia Medical, Inc. (Nasdaq: MOBI), a medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced that members of management will present and host one-on-one investor meetings at the upcoming Piper Sandler 38th Annual Healthcare Conference in New York. The presentation will take place on Tuesday, December 1, 2026, at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time.

**Event: Piper Sandler 38****th** **Annual Healthcare Conference**  
Date: Tuesday, December 1, 2026  
Time: 5:30 a.m. PT / 8:30 a.m. ET  
Webcast: <a href="https://www.globenewswire.com/Tracker?data=I6BzEobU1NDGVEIIQmgtZlbmn1FXrR884Uo_HGTfWxBeVtssLWXOf4OwcR2zW2ClOBLs8988y0PQGO0ja2VupbuYJ6D3DLM4zujjMb98VIAxH1kGo7pglW569ba1KtSDAT5CkdmGtUSxOXzdzcYRA_1YVHmYlrnJoKH3wfYZkRjYRMocAijC6uTsix6CFrpt1rSEQAXeYIFjKE33f1atYqvzMJKcc2L5q7jnMh5UWace-VSK1G_S36FOAQO-njPMUjuADu3V64b0xuB2a5G4kZmTvyjCdLPSPaDUomt-pkfgPJZ-pwTUEyz6JrgaMCPSrkh8M670AXTseoIzL5Qpi69Y1JAnpy5FzXnetTuFMdmUKU0b0dswxcsXwlrbfQZq0kViSO26mebpTFWMPp-xNI38jRxeqlAoVKI7ezcx81DPSbReb6_w81LlPmbtvGc-xXAW_pxPHKlyb26dHpP-iVkYo9uONJq1tLxWV289amTQXcbjhFMFU1bLChqKT5j2yNOOgZFaLp3i0Q8AEBDHSg==" rel="nofollow">https://event.webcasts.com/starthere.jsp?ei=1783629&tp\_key=efbad274e1</a>

A live and archived version of the presentation will be available via the <a href="https://www.globenewswire.com/Tracker?data=3sETfkLGjB3vkqtpMKsTAUPIm33pCKhlvqbOB9akV5nQkl1u7M6uM5CuOXQwoYntRtmDw9ts5-psZYY_AhfsxW0xPAtZTMq7eKU_LjEpYzdd88bXZ8vuK3lH3uZ3Ure7" rel="nofollow">News & Events</a> page of the investor section of Mobia Medical’s website.

**About Mobia Medical, Inc.** 

Mobia Medical, Inc. is a medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The Company’s Vivistim® Paired VNS™ System is the first and only clinically validated, FDA-approved implantable solution designed to improve upper limb function in chronic ischemic stroke survivors with moderate to severe upper extremity impairments. Therapy with the Vivistim® Paired VNS™ System combines targeted vagus nerve stimulation with functional movement to promote neuroplasticity and drive meaningful improvements in motor function. Mobia Medical is mobilizing patients, providers, and care partners to establish a better way forward in stroke care.  

**Investor Relations Contact** 

Louisa Smith  
Gilmartin Group, LLC   
<a href="https://www.globenewswire.com/Tracker?data=KHlnhvmyk8l3UzN_etqqsORAZTFJSPQTzOoxXubEqK6vHOGiPJIDqnwV6H8iFss2xaXodrp1OA01D2T4WY245dx6-XGeYc4rHCul1PjfE2Y=" rel="nofollow">investors@mobia.com</a>

**Media Inquiries Contact**

Terri Clevenger  
<a href="https://www.globenewswire.com/Tracker?data=38hnPRHXwAfj4yXTASFJ7toCThCPN19ug-BsLM6t7jCTu_-I8bakn1nO-1BlGvJq48u0N8DmX3gURAd8Nkz4dBz6dHAgk9rlcLv1-BiVD-A0Mcmt-xXBfnKOirZXTcK1K2XckptTYH9G1WzwFMZUxWIAghSyoI9GjG-FDjFTiFti5T52sZ98lu70nPWJIUfugh_wN0ZZifoN0dhRnVIAtBQ748MH2fMofUW0EQdV6-MRYzmonMYpzLvS155qACMU7QpIUJBGLv6Us8Bj7wpFbOtjCZr8Xf5s9RYjs9voiD3X9HV6wpmd_HsZxSBGSxcT2EA3eRJTqlcpSgaHG21mSg==" rel="nofollow">tclevenger@waterhousebrands.com</a>

  
![](https://ml.globenewswire.com/media/MWE1MTAzMzctY2Q4My00OTEzLThiZTQtMTM3MWQ2ZGY4YWI4LTEzMTk0NjAtMjAyNi0xMS0xNy1lbg==/tiny/Mobia-Medical-Inc-.png)

## Related

- [Generic Nexletol and Nexlizet: a seventh drugmaker agrees to wait until 2040](https://healthcarenews.io/news/generic-nexletol-2040-seventh-settlement.md)
- [Medicare counted 6,436 surgery centers in 2024. Trimedx now offers them equipment maintenance nationwide](https://healthcarenews.io/news/surgery-center-equipment-maintenance-trimedx-nationwide.md)
- [Novartis again leads drugmakers on reaching patients in poorer countries in the 2026 Access to Medicine Index](https://healthcarenews.io/news/2026-access-to-medicine-index-novartis-ranks-first.md)
- [Glanzmann thrombasthenia has no approved preventive treatment. A weekly injection enters its final-stage trial](https://healthcarenews.io/news/glanzmann-thrombasthenia-treatment-weekly-injection-phase-3.md)
